Hematology TimesBlood disorders prove costly for European economyJuly 22, 2016CythemiasAnemiaLeukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaThrombosisBlood Banking
Hematology TimesGene therapy granted breakthrough designation for hemophilia BJuly 22, 2016ThrombosisPharmacy
Hematology TimesEC grants immunotherapy orphan designationJuly 22, 2016Lymphoma & Plasma Cell DisordersPharmacyTransplantationHodgkin LymphomaNon-Hodgkin Lymphoma
Hematology TimesIbrutinib approved for first-line treatment of CLLJuly 21, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA rejects pegfilgrastim biosimilarJuly 20, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacy
Hematology TimesEC approves lenalidomide for rel/ref MCLJuly 16, 2016Lymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin Lymphoma
Hematology TimesFDA lifts hold on phase 2 JCAR015 trialJuly 14, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesCOMP recommends orphan status for drug to treat PNHJuly 13, 2016AnemiaThrombosisPharmacyBleeding Disorders
Hematology TimesDrug’s benefits outweigh risks, PRAC saysJuly 10, 2016Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersPharmacyNon-Hodgkin LymphomaFollicular Lymphoma
Hematology TimesDeaths prompt clinical hold for JCAR015 trialJuly 9, 2016Leukemia, Myelodysplasia, TransplantationPharmacyALL
Hematology TimesNICE recommends approval for bosutinibJuly 8, 2016Leukemia, Myelodysplasia, TransplantationPharmacyCML
Hematology TimesEC extends marketing authorization for brentuximab vedotinJuly 7, 2016Lymphoma & Plasma Cell DisordersPharmacyHodgkin Lymphoma
